Bilaketaren emaitzak - Diana L. Mandelker

Baseline risk of hematologic malignancy at initiation of frontline PARP inhibitor maintenance for BRCA1/2-associated ovarian cancer nork Anastasia Navitski, Duaa H. Al-Rawi, Ying Liu, Maria M. Rubinstein, Claire F. Friedman, Raajit K. Rampal, Diana L. Mandelker, Karen Cadoo, Roisin E. O'Cearbhaill

Connect to this object online.

Evaluating the role of aromatase inhibitors in the treatment of low-grade endometrial stromal sarcomas nork Fionnuala Crowley, Karen A. Cadoo, Sarah Chiang, Diana L. Mandelker, Raazi Bajwa, Alexia Iasonos, Qin C. Zhou, Kathryn M. Miller, Martee L. Hensley, Roisin E. O'Cearbhaill

Connect to this object online.

The ongoing evolution of the core curriculum of a clinical fellowship in pathology informatics nork Andrew M Quinn, Veronica E Klepeis, Diana L Mandelker, Mia Y Platt, Luigi K F Rao, Gregory Riedlinger, Jason M Baron, Victor Brodsky, Ji Yeon Kim, William Lane, Roy E Lee, Bruce P Levy, David S McClintock, Bruce A Beckwith, Frank C Kuo, John R Gilbertson

Connect to this object online.